Brief: ASKA Pharmaceutical signs option agreement with Pieris Pharmaceuticals on anemia treatment drug PRS-080

ASKA Pharmaceutical Holdings

28/02/2017 02:03

Feb 28 (Reuters) - ASKA Pharmaceutical Co Ltd  4514.T  : 
     
    * Says the company enters into an exclusive option agreement 
with Pieris Pharmaceuticals on development and sale of anemia 
treatment drug PRS-080 in Japan, Korea and other Asian countries 
 
    Source text in Japanese: https://goo.gl/Zhxlfg 
    Further company coverage: 4514.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))